Long Term Maintenance of Sinus Rhythm by Combined Valve and Arrhythmia Surgery in Patients With Mitral Valve Disease and Atrial Fibrillation

1998 ◽  
Vol 31 (2) ◽  
pp. 152A
Author(s):  
A Tuinenburg
EP Europace ◽  
2020 ◽  
Vol 22 (Supplement_1) ◽  
Author(s):  
M S Van Schie ◽  
R Starreveld ◽  
M C Roos-Serote ◽  
A J J C Bogers ◽  
N M S De Groot

Abstract Funding Acknowledgements CVON-AFFIP [grant number 914728], NWO-Vidi [grant number 91717339], Biosense Webster USA [ICD 783454] and Medical Delta Background Voltage mapping is increasingly used for identifying the substrate of cardiac arrhythmias like atrial fibrillation (AF). Low bipolar voltage areas are regarded as indicators of structurally remodeled tissue. However, non-substrate related factors such as wavefront activation direction also influence voltages of bipolar EGMs. Unipolar electrograms (U-EGMs), on the other hand, are independent of the electrode orientation and atrial wavefront direction. It is for these reasons that U-EGMs are increasingly used in electrophysiological studies and newly developed mapping systems guiding ablation procedures. Objective The goal of this study is to examine U-EGM voltages at a high resolution scales during sinus rhythm (SR) in patients with mitral valve disease (MVD). Methods Intra-operative epicardial mapping (interelectrode distance 2mm) of the right and left atrium (RA, LA), Bachmann’s Bundle (BB) and pulmonary vein area (PVA) was performed during SR in 67 patients (27 male, 67 ± 11 years) with or without a history of paroxysmal atrial fibrillation (PAF). U-EGMs were analyzed according to their potential type and peak-to-peak voltage. Low voltage was defined as the proportion of potentials with an amplitude below 1.0 mV. Results In all patients, there was a considerable variation in voltage distribution between all atrial regions and clear inter-individual differences were found. In patients without AF, there were no statistical differences in median potential voltages between the various atrial regions (P = 0.869). In the PAF group, however, unipolar voltages of BB potentials were lower compared to RA potentials (3.30 [2.25–4.57] mV vs. 4.64 [3.85–6.08] mV, P = 0.006) and LA potentials (3.30 [2.25–4.57] mV vs. 4.86 [3.72–5.86] mV, P = 0.009). In addition, unipolar voltages at BB were lower in the patients with PAF compared to those without AF (no AF: 4.94 [3.56–5.98] mV, PAF:  3.30 [2.25–4.57] mV, P = 0.006). A larger number of low voltage potentials were recorded at BB in the PAF group (no AF: 2.13 [0.52–7.68] %, PAF: 12.86 [3.18–23.59] %, P = 0.001). In addition, a higher number of fractionated potentials was found in patients with PAF at the PVA (12.81 [9.19–18.03] % vs. 20.94 [13.54–27.37] %, P < 0.001) and LA (11.47 [7.30–18.30] % vs. 17.80 [12.93–21.34] %, P = 0.045). Lower voltages were found in potentials with a progressively higher degree of fractionation (R=-0.76, P < 0.001). Conclusions Even in SR, patients with MVD and AF episodes are characterized by decreased potential voltages at BB and a higher degree of low voltage potentials. Both considerable intra- and inter-individual variation in potential voltages were found in our study population, which underlines the interest of an individualized electrical signal profile which can be used to characterize complex conduction disorders. Abstract Figure. Epicardial voltage maps


1996 ◽  
Vol 27 (2) ◽  
pp. 188 ◽  
Author(s):  
Fang-Yue Lin ◽  
Huey-Ming Lo ◽  
Jiunn-Lee Lin ◽  
Juey-Jen Hwang ◽  
Shoei K.Stephen Huang ◽  
...  

2018 ◽  
Vol 33 (3) ◽  
pp. 63-70
Author(s):  
A. V. Bogachev-Prokophiev ◽  
S. I. Zheleznev ◽  
M. A. Ovcharov ◽  
A. V. Afanasyev ◽  
R. M. Sharifulin ◽  
...  

Objective. Main objective of this prospective randomized study was to assess safety and efficiency of the combined approach for the left atrial ablation in combination with and without reduction left atrioplasty in patients with mitral valve disease.Material and Methods. The study was performed from September, 2014 to February, 2017. A total of 120 patients with mitral valve disease, permanent atrial fibrillation (AF), and left atriomegaly were enrolled in the study. Patients were randomized to two groups: group I comprised patients who received correction of mitral valve disease in combination with AF ablation and without reduction atrioplasty of the left atrium (MV+MAZE); group II (n=60) comprised patients with correction of mitral valve disease in combination with AF ablation and with reduction atrioplasty of the left atrium (MV+MAZE+AP). Patient characteristics did not differ between groups.Results. There were no significant differences between groups in the early mortality rates (2 patients in group I versus 5 patients in group II, p=0.64); bleeding rates (total 5 cases including 2 patients in group I and 3 patients in group II, p=0.34), and the rates of AF recurrence in the early postoperative period. Permanent pacemakers were implanted in 8 patients (13.3%) of group I and in 4 patients (6.7%) of group II. Total long-term mortality was 4 patients including 1 and 3 patients in group I and II, respectively, which did not significantly differed. The rates of one-year freedom from AF were 84.8 and 86.2% in group I and II, respectively. No new onsets of atrial fibrillation were observed for 36 months in both groups. The rates of freedom from thromboembolic events during the time of observation were 88.6% in group I and 96.5% in group II. Conclusion. The left atrial reduction concomitant with the left atrial ablation and correction of mitral valve disease is safe and effective procedure. However, this procedure did not impact the rates of long-term freedom from AF.


2019 ◽  
Vol 17 (2) ◽  
pp. 7-9
Author(s):  
Anil Shrestha ◽  
Richa Shrestha

Aim: To study the correlation between Atrial Fibrillation (AF) and left atrial size in Rheumatic Mitral valve disease (RMVD). Background: AF is the most common sustained cardiac arrhythmia which is associated with increased cardiovascular morbidity, mortality and preventable stroke. AF is common in rheumatic heart disease (RHD) particularly mitral stenosis (MS). LA dilatation is the predisposing factor for the development of AF in RMVD. Methodology: This is a hospital based cross sectional descriptive study conducted in 52 patients who were diagnosed as RMVD clinically and echocardiographically in NGMCTH, Kohalpur between December 2018 to November 2019. Detailed history and complete clinical examination were performed. Standard 12 lead ECG and 2-D echocardiography were done. Left atrial size was measured and compared with patients in AF and with sinus rhythm. Result: The age of patients ranged from 20-76 years with the mean age of 40.33 years. Out of 52 patients 30 were in AF and 23 in sinus rhythm. Among 30 patients in AF, 27 (90%) had LA size ≥ 4 cm with mean LA size of 4.6 cm whereas among 22 patients in sinus rhythm, 14 (63.64%) had LA Size <4 cm with a mean of 3.83 cm. Conclusion: Left atrial size ≥ 4 cm is the predisposing factor for the development of AF in rheumatic mitral valve disease. Therefore, if patients in sinus rhythm who are at high risk of developing AF are identified, prophylactic anticoagulation and antiarrythmic drug might prevent AF induced embolism and exacerbation of symptoms in rheumatic mitral valve disease.  


2020 ◽  
Vol 8 (1) ◽  
pp. 7
Author(s):  
Malli Dorasanamma ◽  
U. Gangaram ◽  
B. Indeevar Prasad

Background: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia which is as associated with increased cardiovascular morbidity, mortality and preventable stroke. AF is common in rheumatic heart disease (RHD) particularly mitral stenosis (MS). Left atrial (LA) dilatation is the predisposing factor for the development of AF in rheumatic mitral valve disease. Aim was to study the correlation between AF and LA size in rheumatic mitral valve disease in the population of Southern Andhra Pradesh.  Methods: This is a prospective, observational study conducted in 42 patients diagnosed to have RMVD in Narayana Medical College and Hospital, Nellore, Andhra Pradesh between August 2018 and July 2020. Detailed patient history and complete clinical examination were performed. Standard 12 lead Electrocardiography (ECG) and 2-D echocardiography were done. Left atrial size was measured and compared with patients in AF and with sinus rhythm.  Results: The age of patients ranged from 20-76 years with the mean age of 40.33 years. Out of 42 patients 26 were in AF and 16 in sinus rhythm. Among 26 patients in AF, 22 (84.6%) had LA size ≥4 cm and 4 (15.38%) had <4 cm with mean LA size of 4.6 cm whereas among 16 patients in sinus rhythm, 10 (62.5%) had LA size <4 cm and 6 (37.5%) had ≥4 cm with a mean of 3.83 cm.  Conclusions: Left atrial size ≥4 cm is the predisposing factor for the development of AF in rheumatic mitral valve disease. Therefore, if patients in sinus rhythm who are at high risk of developing AF are identified, prophylactic anticoagulation and antiarrythmic drugs might prevent AF induced complications like embolism and symptom exacerbation in rheumatic mitral valve disease.


Sign in / Sign up

Export Citation Format

Share Document